A detailed history of Gratus Wealth Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Gratus Wealth Advisors, LLC holds 11,103 shares of ABT stock, worth $1.27 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
11,103
Previous 11,911 6.78%
Holding current value
$1.27 Million
Previous $1.22 Billion 3.57%
% of portfolio
0.21%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$100.07 - $118.13 $80,856 - $95,449
-808 Reduced 6.78%
11,103 $1.26 Billion
Q2 2024

Jul 22, 2024

SELL
$100.73 - $112.44 $62,452 - $69,712
-620 Reduced 4.95%
11,911 $1.22 Billion
Q1 2024

May 09, 2024

BUY
$109.52 - $120.96 $214,768 - $237,202
1,961 Added 18.55%
12,531 $1.32 Billion
Q4 2023

May 09, 2024

BUY
$90.19 - $110.4 $953,308 - $1.17 Million
10,570 New
10,570 $1.16 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Gratus Wealth Advisors, LLC Portfolio

Follow Gratus Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Wealth Advisors, LLC with notifications on news.